ROCKVILLE, Md., July 30, 2020 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback